Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication

Georges Natsoulis, Partha Seshaiah, Mark J. Federspiel, Alan Rein, Stephen H. Hughes, Jef D. Boeke

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Capsid-targeted viral inactivation is an antiviral strategy in which toxic fusion proteins are targeted to virions, where they inhibit viral multiplication by destroying viral components. These fusion proteins consist of a virion structural protein moiety and an enzymatic moiety such as a nuclease. Such fusion proteins can severely inhibit transposition of yeast retrotransposon Ty1, an element whose transposition mechanistically resembles retroviral multiplication. We demonstrate that expression of a murine retrovirus capsid-staphylococcal nuclease fusion protein inhibits multiplication of the corresponding murine leukemia virus by 30- to 100- fold. Staphylococcal nuclease is apparently inactive intracellularly and hence nontoxic to the host cell, but it is active extracellularly because of its requirement for high concentrations of Ca2+ ions. Virions assembled in and shed from cells expressing the fusion protein contain very small amounts of intact viral RNA, as would be predicted for nuclease-mediated inhibition of viral multiplication.

    Original languageEnglish (US)
    Pages (from-to)364-368
    Number of pages5
    JournalProceedings of the National Academy of Sciences of the United States of America
    Volume92
    Issue number2
    DOIs
    StatePublished - Jan 17 1995

    Keywords

    • antivirals
    • gene therapy
    • staphylococcal nuclease

    ASJC Scopus subject areas

    • General

    Fingerprint

    Dive into the research topics of 'Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication'. Together they form a unique fingerprint.

    Cite this